IMAC Holdings, Inc. Announces the Launch of Spinal Health and Wellness Products and Supplements
June 15, 2022 09:30 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., June 15, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), today announces the launch of retail healthcare products for optimal spinal health...
IMAC Holdings Reports Increased Revenue for the Fourth Consecutive Quarter
May 13, 2022 08:00 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., May 13, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative...
IMAC Holdings Expands The Back Company Presence in Central Florida
April 29, 2022 09:30 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., April 29, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), today announces the selection of two The Back Space locations in the Orlando...
IMAC Holdings Completes Walmart Pilot Program, Affirms Commitment to Growth
April 07, 2022 08:47 ET
|
IMAC Holdings, Inc.
The Company plans to add 20 locations in the next 12 months BRENTWOOD, Tenn., April 07, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), today announces the...
IMAC Holdings Reports Preliminary Fourth Quarter and Year End 2021 Financial Results and Corporate Update
March 31, 2022 09:00 ET
|
IMAC Holdings, Inc.
Revenue increased 26% for quarter and 12% annually BRENTWOOD, Tenn., March 31, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative...
IMAC Holdings, Inc. Announces Initiation of Third and Final Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
March 24, 2022 08:00 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn, March 24, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has initiated the third and final cohort of its Phase 1 clinical...
IMAC Holdings launches The Back Company Franchise
March 15, 2022 09:00 ET
|
IMAC Holdings, Inc.
Expansion plan leverages Walmart pilot to meet growing demand for spinal health and wellness BRENTWOOD, Tenn., March 15, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or...
IMAC Holdings, Inc. Announces Completion of Second Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
February 16, 2022 09:30 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., Feb. 16, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has completed the second cohort of its Phase 1 clinical trial for...
IMAC Holdings, Inc., Announces Dr. Ben Lerner as Chief Operating Officer
February 09, 2022 09:25 ET
|
IMAC Holdings, Inc.
Dr. Lerner, a New York Times best-selling author and holistic health and business expert, brings healthcare growth experience to IMAC executive team. BRENTWOOD, Tenn., Feb. 09, 2022 (GLOBE...
IMAC Holdings, Inc. Enters 2022 with Improved Balance Sheet
January 19, 2022 08:30 ET
|
IMAC Holdings, Inc.
Company reduces significant debt in 2021 BRENTWOOD, Tenn., Jan. 19, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical...